Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Compassionate Use of Omegaven for Pediatric Patients With Parenteral Nutrition Associated Liver Disease (Omegaven)

Expanded access is currently available for this treatment.
Verified September 2016 by Children's Hospital of Philadelphia
Sponsor:
Information provided by (Responsible Party):
Maria Mascarenhas, Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier:
NCT01297933
First received: February 15, 2011
Last updated: September 14, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: Expanded access is currently available for this treatment.
  Estimated Study Completion Date: January 2017
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)